Monopar Therapeutics Inc. buy BiotechBee
Start price
08.06.24
/
50%
€0.71
Target price
31.01.26
€1.00
Performance (%)
-12.77%
Price
26.07.24
€0.60
Summary
This prediction is currently active. The price of Monopar Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.77%. This prediction currently runs until 31.01.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Monopar Therapeutics Inc. | - | - |
iShares Core DAX® | -0.598% | 0.645% |
iShares Nasdaq 100 | -3.290% | -4.193% |
iShares Nikkei 225® | -0.796% | -0.582% |
iShares S&P 500 | -1.164% | -0.857% |
According to BiotechBee what are the pros and cons of Monopar Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Monopar Therapeutics Inc. diskutieren
Buy mit Kursziel 1,0